Dr. Menon will be speaking at the FierceBiotech Dr
Post# of 72440
Add Orphan Indications to Accelerate Development
- Target orphan drug indications to obtain extended periods of exclusivity for blockbuster therapeutics
- Anticipate changes now that politicians and payers expect this
- Weigh the prospect of changes to the orphan drug program, either legislatively or at the FDA regulatory level
http://www.fiercedrugdevforum.com/agenda